These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 3838691

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide.
    Watkins LR, Kinscheck IB, Mayer DJ.
    Science; 1984 Apr 27; 224(4647):395-6. PubMed ID: 6546809
    [Abstract] [Full Text] [Related]

  • 3. Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide.
    Watkins LR, Kinscheck IB, Mayer DJ.
    Brain Res; 1985 Feb 18; 327(1-2):169-80. PubMed ID: 3838690
    [Abstract] [Full Text] [Related]

  • 4. Potentiation of systemic morphine analgesia in humans by proglumide, a cholecystokinin antagonist.
    Price DD, von der Gruen A, Miller J, Rafii A, Price C.
    Anesth Analg; 1985 Aug 18; 64(8):801-6. PubMed ID: 4014744
    [Abstract] [Full Text] [Related]

  • 5. Chronic administration of cholecystokinin antagonists reverses the enhancement of spinal morphine analgesia induced by acute pretreatment.
    Kellstein DE, Mayer DJ.
    Brain Res; 1990 May 21; 516(2):263-70. PubMed ID: 2364292
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The nature of conditioned anti-analgesia: spinal cord opiate and anti-opiate neurochemistry.
    Wiertelak EP, Yang HY, Mooney-Heiberger K, Maier SF, Watkins LR.
    Brain Res; 1994 Jan 21; 634(2):214-26. PubMed ID: 8131071
    [Abstract] [Full Text] [Related]

  • 8. Opiate antagonistic function of cholecystokinin in analgesia and energy balance systems.
    Faris PL.
    Ann N Y Acad Sci; 1985 Jan 21; 448():437-47. PubMed ID: 3861127
    [Abstract] [Full Text] [Related]

  • 9. The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia.
    Benedetti F.
    Pain; 1996 Mar 21; 64(3):535-543. PubMed ID: 8783319
    [Abstract] [Full Text] [Related]

  • 10. [Cholecystokinin octapeptide (CCK-8) antagonized analgesia mediated by mu and kappa opioid receptors].
    Wang XH, Wang XJ, Han JS.
    Sheng Li Xue Bao; 1990 Jun 21; 42(3):219-25. PubMed ID: 1982023
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Behavioral evidence for cholecystokinin-opiate interactions in neonatal rats.
    Weller A, Blass EM.
    Am J Physiol; 1988 Dec 21; 255(6 Pt 2):R901-7. PubMed ID: 3202224
    [Abstract] [Full Text] [Related]

  • 13. Morphine-induced analgesia in the rat paw pressure test is blocked by CCK and enhanced by the CCK antagonist MK-329.
    O'Neill MF, Dourish CT, Iversen SD.
    Neuropharmacology; 1989 Mar 21; 28(3):243-7. PubMed ID: 2725851
    [Abstract] [Full Text] [Related]

  • 14. Kappa opiate receptors mediate tail-shock induced antinociception at spinal levels.
    Watkins LR, Wiertelak EP, Maier SF.
    Brain Res; 1992 Jun 05; 582(1):1-9. PubMed ID: 1354010
    [Abstract] [Full Text] [Related]

  • 15. Cholecystokinin octapeptide antagonized opioid analgesia mediated by mu- and kappa- but not delta-receptors in the spinal cord of the rat.
    Wang XJ, Wang XH, Han JS.
    Brain Res; 1990 Jul 16; 523(1):5-10. PubMed ID: 1976419
    [Abstract] [Full Text] [Related]

  • 16. Cholecystokinin and pain: a review.
    McRoberts JW.
    Anesth Prog; 1986 Jul 16; 33(2):87-90. PubMed ID: 2872841
    [Abstract] [Full Text] [Related]

  • 17. The role of CCK caerulein, and CCK antagonists in nociception.
    Baber NS, Dourish CT, Hill DR.
    Pain; 1989 Dec 16; 39(3):307-328. PubMed ID: 2694075
    [Abstract] [Full Text] [Related]

  • 18. Antianalgesic action of dynorphin A mediated by spinal cholecystokinin.
    Rady JJ, Holmes BB, Fujimoto JM.
    Proc Soc Exp Biol Med; 1999 Mar 16; 220(3):178-83. PubMed ID: 10193446
    [Abstract] [Full Text] [Related]

  • 19. Spinal co-administration of cholecystokinin antagonists with morphine prevents the development of opioid tolerance.
    Kellstein DE, Mayer DJ.
    Pain; 1991 Nov 16; 47(2):221-229. PubMed ID: 1762818
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.